Evidence map›Paper›PMID 26656917›Full record

ArticlePloS one2015

Deep Sequencing Reveals the Effect of MeJA on Scutellarin Biosynthesis in Erigeron breviscapus.

Rui-Bing Chen, Jiang-Hua Liu, Ying Xiao, Feng Zhang, Jun-feng Chen, Qian Ji, He-Xin Tan, Xin Huang, Hao Feng, Bao-Kang Huang and 2 more

Open access · goldAbstract read
In one paragraph

Article in PloS one, 2015. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 9 papers.

0numbers the graph read from it
0cells of the map it votes in
9citing papers in PubMed
1.1field-weighted citation impact, top 23% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

9 citing papers in PubMed, 18 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Researches on Transcriptome Sequencing in the Study of Traditional Chinese Medicine.Evidence-based complementary and alternative medicine : eCAM · 2017
    Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

12 authors at 3 institutions in 1 country.

Rui-Bing ChenDepartment of Pharmaceutical Botany, School of Pharmacy, Second Military Medical University, Shanghai 200433, P. R. China.
Jiang-Hua LiuSchool of Forestry, Southwest Forestry University, Kunming, Yunnan, 650224, P. R. China.
Ying XiaoDepartment of Pharmacy, Shanghai Changzheng Hospital, Second Military Medical University, Shanghai 200003, P. R. China.
Feng ZhangDepartment of Pharmacy, Shanghai Changzheng Hospital, Second Military Medical University, Shanghai 200003, P. R. China.
Jun-feng ChenDepartment of Pharmacy, Shanghai Changzheng Hospital, Second Military Medical University, Shanghai 200003, P. R. China.
Qian JiDepartment of Pharmaceutical Botany, School of Pharmacy, Second Military Medical University, Shanghai 200433, P. R. China.
He-Xin TanDepartment of Pharmaceutical Botany, School of Pharmacy, Second Military Medical University, Shanghai 200433, P. R. China.
Xin HuangDepartment of Pharmaceutical Botany, School of Pharmacy, Second Military Medical University, Shanghai 200433, P. R. China.
Hao FengBusiness Development & Strategic Planning Central Research Institute, Shanghai Pharmaceuticals Holding Co., ltd, Shanghai 200021, P. R. China.
Bao-Kang HuangDepartment of Pharmacognosy, School of Pharmacy, Second Military Medical University, Shanghai 200433, P. R. China.
Wan-Sheng ChenDepartment of Pharmacy, Shanghai Changzheng Hospital, Second Military Medical University, Shanghai 200003, P. R. China.
Lei ZhangDepartment of Pharmaceutical Botany, School of Pharmacy, Second Military Medical University, Shanghai 200433, P. R. China.
Second Military Medical University · CNShanghai Changzheng Hospital · CNSouthwest Forestry University · CN

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundErigeron breviscapus, a well-known traditional Chinese medicinal herb, is broadly used in the treatment of cerebrovascular disease. Scutellarin, a kind of flavonoids, is considered as the material base of the pharmaceutical activities in E. breviscapus. The stable and high content of scutellarin is critical for the quality and efficiency of E. breviscapus in the clinical use. Therefore, understanding the molecular mechanism of scutellarin biosynthesis is crucial for metabolic engineering to increase the content of the active compound. However, there is virtually no study available yet concerning the genetic research of scutellarin biosynthesis in E. breviscapus.

resultsUsing Illumina sequencing technology, we obtained over three billion bases of high-quality sequence data and conducted de novo assembly and annotation without prior genome information. A total of 182,527 unigenes (mean length = 738 bp) were found. 63,059 unigenes were functionally annotated with a cut-off E-value of 10(-5). Next, a total of 238 (200 up-regulated and 38 down-regulated genes) and 513 (375 up-regulated and 138 down-regulated genes) differentially expressed genes were identified at different time points after methyl jasmonate (MeJA) treatment, which fell into categories of 'metabolic process' and 'cellular process' using GO database, suggesting that MeJA-induced activities of signal pathway in plant mainly led to re-programming of metabolism and cell activity. In addition, 13 predicted genes that might participate in the metabolism of flavonoids were found by two co-expression analyses in E. breviscapus.

conclusionsOur study is the first to provide a transcriptome sequence resource for E. breviscapus plants after MeJA treatment and it reveals transcriptome re-programming upon elicitation. As the result, several putative unknown genes involved in the metabolism of flavonoids were predicted. These data provide a valuable resource for the genetic and genomic studies of special flavonoids metabolism and further metabolic engineering in E. breviscapus.

Indexed as

AcetatesApigeninBase SequenceCyclopentanesDNA, PlantDrugs, Chinese HerbalErigeronGene Expression ProfilingGene Expression Regulation, PlantGenes, PlantGlucuronatesHigh-Throughput Nucleotide SequencingMolecular Sequence AnnotationOxylipinsPlant Growth RegulatorsSequence Analysis, DNAAcetatesApigeninCyclopentanesDNA, PlantDrugs, Chinese HerbalGlucuronatesmethyl jasmonateOxylipinsPlant Growth Regulatorsscutellarin

Identifiers

PMID26656917
PMCPMC4687647
OpenAlexW2212511459

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.